{"component": "definition", "props": {"groups": [{"samples": [{"hash": "ljaEN1aTlqH", "uri": "/contracts/ljaEN1aTlqH#joint-development-committee", "label": "Clinical Trial Collaboration and Supply Agreement (BioLineRx Ltd.)", "score": 33.2026023865, "published": true}, {"hash": "kuuf3WUlJkh", "uri": "/contracts/kuuf3WUlJkh#joint-development-committee", "label": "Clinical Trial Collaboration and Supply Agreement (Edge Therapeutics, Inc.)", "score": 30.0650234222, "published": true}, {"hash": "dfWSCo0q8Qe", "uri": "/contracts/dfWSCo0q8Qe#joint-development-committee", "label": "Clinical Trial Collaboration and Supply Agreement (Nugenerex Immuno-Oncology, Inc.)", "score": 29.4449005127, "published": true}], "snippet_links": [], "size": 113, "snippet": "or \u201cJDC\u201d has the meaning set forth in Section 3.10.", "hash": "659d73eeaa16b68d9b4dc8f53a9feb6f", "id": 1}, {"samples": [{"hash": "kR5CZxxyBFk", "uri": "/contracts/kR5CZxxyBFk#joint-development-committee", "label": "Clinical Trial Collaboration and Supply Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}, {"hash": "hcgmuw6tJZt", "uri": "/contracts/hcgmuw6tJZt#joint-development-committee", "label": "Clinical Trial Collaboration and Supply Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}, {"hash": "4AFrotDm7qm", "uri": "/contracts/4AFrotDm7qm#joint-development-committee", "label": "Clinical Trial Collaboration and Supply Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}], "snippet_links": [{"key": "the-committee", "type": "clause", "offset": [15, 28]}, {"key": "by-the-parties", "type": "clause", "offset": [47, 61]}, {"key": "section-23", "type": "clause", "offset": [74, 85]}], "size": 79, "snippet": "or \u201cJDC\u201d means the committee to be established by the Parties pursuant to Section 2.3 (Joint Development Committee; Managers).", "hash": "684bfb39cf40a367a65bf011c1f17544", "id": 2}, {"samples": [{"hash": "kE0B3kMsI3a", "uri": "/contracts/kE0B3kMsI3a#joint-development-committee", "label": "Co Development and Option Agreement (Alector, Inc.)", "score": 30.0157432556, "published": true}, {"hash": "1WnmvkCFaL9", "uri": "/contracts/1WnmvkCFaL9#joint-development-committee", "label": "Co Development and Option Agreement (Alector, Inc.)", "score": 29.7775497437, "published": true}, {"hash": "8XQXSot3AyX", "uri": "/contracts/8XQXSot3AyX#joint-development-committee", "label": "Exclusive License Agreement (Ablynx NV)", "score": 28.7508563995, "published": true}], "snippet_links": [], "size": 61, "snippet": "or \u201cJDC\u201d has the meaning set forth in Section 2.2.1.", "hash": "4a0c6efb45ad2ef1776758cded7cfcda", "id": 3}, {"samples": [{"hash": "3qruouJovwt", "uri": "/contracts/3qruouJovwt#joint-development-committee", "label": "Exclusive Licence Agreement", "score": 31.3408622742, "published": true}, {"hash": "ydHKckhj0g", "uri": "/contracts/ydHKckhj0g#joint-development-committee", "label": "Exclusive Licence Agreement (Ascendis Pharma a/S)", "score": 28.2511978149, "published": true}, {"hash": "7zVkE6mbhR3", "uri": "/contracts/7zVkE6mbhR3#joint-development-committee", "label": "Exclusive Licence Agreement (Ascendis Pharma a/S)", "score": 28.2511978149, "published": true}], "snippet_links": [{"key": "the-joint", "type": "definition", "offset": [15, 24]}, {"key": "committee-established", "type": "clause", "offset": [37, 58]}, {"key": "under-clause", "type": "clause", "offset": [59, 71]}], "size": 41, "snippet": "or \u201cJDC\u201d means the joint development committee established under Clause 4.6.", "hash": "a056b20ecc2485fb283d1139479a8f6f", "id": 4}, {"samples": [{"hash": "c4rRrQkRqH3", "uri": "/contracts/c4rRrQkRqH3#joint-development-committee", "label": "Technology Transfer Agreement (Neothetics, Inc.)", "score": 25.7912387848, "published": true}, {"hash": "dAocYqsn5Dy", "uri": "/contracts/dAocYqsn5Dy#joint-development-committee", "label": "Technology Transfer Agreement (Regado Biosciences Inc)", "score": 24.3237514496, "published": true}, {"hash": "iWiA63bTUbN", "uri": "/contracts/iWiA63bTUbN#joint-development-committee", "label": "Technology Transfer Agreement (Regado Biosciences Inc)", "score": 24.2717323303, "published": true}], "snippet_links": [{"key": "section-54", "type": "clause", "offset": [34, 45]}], "size": 30, "snippet": "or \u201cJDC\u201d has the meaning given in Section 5.4, below.", "hash": "6f850498763d3cefe1ccce9b9154ae54", "id": 5}, {"samples": [{"hash": "emcWcWxpiYk", "uri": "/contracts/emcWcWxpiYk#joint-development-committee", "label": "License Agreement (NeuroBo Pharmaceuticals, Inc.)", "score": 33.7008895874, "published": true}, {"hash": "6ADndm5OpBJ", "uri": "/contracts/6ADndm5OpBJ#joint-development-committee", "label": "Phase I/Ib Combination Study Agreement (Corvus Pharmaceuticals, Inc.)", "score": 31.8254623413, "published": true}, {"hash": "1Swue2qCrG3", "uri": "/contracts/1Swue2qCrG3#joint-development-committee", "label": "Clinical Collaboration Agreement (Humanigen, Inc)", "score": 30.6125946045, "published": true}], "snippet_links": [{"key": "defined-in-section", "type": "clause", "offset": [12, 30]}], "size": 29, "snippet": "or \u201cJDC\u201d is defined in Section 3.1(a).", "hash": "acd02433e1d0d46d8deac5ff59b2efb2", "id": 6}, {"samples": [{"hash": "iLy8aaY6QuA", "uri": "/contracts/iLy8aaY6QuA#joint-development-committee", "label": "Collaboration Agreement (Genentech Inc)", "score": 21.0, "published": true}, {"hash": "7ccpbupvKVc", "uri": "/contracts/7ccpbupvKVc#joint-development-committee", "label": "Collaboration Agreement (Idec Pharmaceuticals Corp / De)", "score": 21.0, "published": true}, {"hash": "57zWjMDFf7v", "uri": "https://investors.biogen.com/static-files/2832a444-3e38-45ed-9ad5-25170448a222", "label": "Proxy", "score": 13.1738538742, "published": false}], "snippet_links": [{"key": "committee-established", "type": "clause", "offset": [20, 41]}, {"key": "section-32", "type": "definition", "offset": [54, 65]}, {"key": "collaboration-agreement", "type": "definition", "offset": [73, 96]}], "size": 21, "snippet": "or \"JDC\" means that committee established pursuant to Section 3.2 of the Collaboration Agreement.", "hash": "d1ff7e4256108610bcf6b65543d017d0", "id": 7}, {"samples": [{"hash": "aqqfj3FR3dp", "uri": "/contracts/aqqfj3FR3dp#joint-development-committee", "label": "License and Commercialization Agreement (Bellerophon Therapeutics, Inc.)", "score": 26.2429847717, "published": true}, {"hash": "642nEY2fakH", "uri": "/contracts/642nEY2fakH#joint-development-committee", "label": "License and Commercialization Agreement (BioLineRx Ltd.)", "score": 26.22108078, "published": true}, {"hash": "eqgtMpj78Xc", "uri": "/contracts/eqgtMpj78Xc#joint-development-committee", "label": "License and Commercialization Agreement (Bellerophon Therapeutics LLC)", "score": 26.032169342, "published": true}], "snippet_links": [{"key": "section-32", "type": "definition", "offset": [9, 20]}], "size": 18, "snippet": "or \u201cJDC\u201d Section 3.2", "hash": "a1c078637db0126e0f7a23fff8498d25", "id": 8}, {"samples": [{"hash": "2ZIje2dikM2", "uri": "/contracts/2ZIje2dikM2#joint-development-committee", "label": "Development Collaboration and Commercial License Agreement (Mersana Therapeutics, Inc.)", "score": 28.414100647, "published": true}, {"hash": "7nNtuHvo9o3", "uri": "/contracts/7nNtuHvo9o3#joint-development-committee", "label": "Development Collaboration and Commercial License Agreement (Mersana Therapeutics, Inc.)", "score": 28.2060241699, "published": true}], "snippet_links": [{"key": "section-33", "type": "definition", "offset": [29, 40]}], "size": 17, "snippet": "has the meaning set forth in Section 3.3.", "hash": "7b1b90b3e7cfed54b67a306376a41934", "id": 9}, {"samples": [{"hash": "bshuXmUJQK8", "uri": "/contracts/bshuXmUJQK8#joint-development-committee", "label": "License, Development and Commercialization Agreement (Fibrogen Inc)", "score": 31.8446273804, "published": true}, {"hash": "gsNN9y0tg3O", "uri": "/contracts/gsNN9y0tg3O#joint-development-committee", "label": "Collaboration Agreement (Blueprint Medicines Corp)", "score": 31.5790557861, "published": true}, {"hash": "2pRa9THPkRz", "uri": "/contracts/2pRa9THPkRz#joint-development-committee", "label": "License, Development and Commercialization Agreement (Fibrogen Inc)", "score": 28.950717926, "published": true}], "snippet_links": [{"key": "the-committee", "type": "clause", "offset": [15, 28]}, {"key": "by-the-parties", "type": "clause", "offset": [36, 50]}, {"key": "section-23", "type": "clause", "offset": [67, 78]}], "size": 10, "snippet": "or \u201cJDC\u201d means the committee formed by the Parties as described in Section 2.3.", "hash": "13856abeb4c4d4ec68a928a3f87a9ca3", "id": 10}], "next_curs": "CmgSYmoVc35sYXdpbnNpZGVyY29udHJhY3RzckQLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIkam9pbnQtZGV2ZWxvcG1lbnQtY29tbWl0dGVlIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Joint Development Committee", "size": 624, "snippet": "or \u201cJDC\u201d has the meaning set forth in Section 3.10.", "id": "joint-development-committee", "examples": ["Each Party shall provide Samples to the other Party as specified in the Protocol and as agreed to by the <strong>Joint Development Committee</strong>."], "related": [["development-committee", "Development Committee", "Development Committee"], ["steering-committee", "Steering Committee", "Steering Committee"], ["joint-steering-committee", "Joint Steering Committee", "Joint Steering Committee"], ["joint-commercialization-committee", "Joint Commercialization Committee", "Joint Commercialization Committee"], ["joint-committee", "Joint Committee", "Joint Committee"]], "related_snippets": [], "updated": "2026-02-25T05:25:33+00:00"}, "json": true, "cursor": ""}}